Yurke
Benard Yurke, Boise, ID US
Patent application number | Description | Published |
---|---|---|
20090195782 | PLASMONIC DEVICE FOR MODULATION AND AMPLIFICATION OF PLASMONIC SIGNALS - According to one embodiment of the invention, a plasmonic device has a beam splitter adapted to split a surface-plasmon (SP) input beam into first and second SP beams and direct them along first and second propagation paths, respectively. One of the propagation paths has a plasmonic-beam interaction region adapted to controllably change the phase of the corresponding split beam within that interaction region in response to an SP control signal applied thereto. The plasmonic device further has an SP beam mixer adapted to receive the first and second beams from their respective propagation paths and to mix them to produce an SP output signal. In various configurations, the plasmonic device can operate as a plasmonic-signal amplifier, a plasmonic-beam router, a 1×2 plasmonic-beam switch, and/or a plasmonic modulator. | 08-06-2009 |
Bernard Yurke, Plainfield, NJ US
Patent application number | Description | Published |
---|---|---|
20100292402 | COMPOSITIONS THAT REVERSIBLY GEL AND DE-GEL - The present invention provides a composition comprising a first polymer and a second polymer cross-linked by the association of functional groups attached as side chains to the polymers. | 11-18-2010 |
Bernard Yurke US
Patent application number | Description | Published |
---|---|---|
20130202582 | AGENT DELIVERY SYSTEM CAPABLE OF SELECTIVELY RELEASING AN AGENT - The present invention provides a composition for selectively delivering an active agent to a portion of an organism. The composition comprises first and second polymer portions, having first and second functional groups attached as a side-chain thereto, respectively. The first and second functional groups form cross-links between the first and second polymer portions. The cross-links are capable of being broken by a substance of the organism, thereby resulting in release of the active agent. The composition provides a novel means for controlling the selective release of the active agent in the organism. | 08-08-2013 |